HP
41
-4
FLR
52
4
FRT
36
-2
ACN
56
13
PRGO
44
-2
SWK
81
-3
C
60
-2
SWN
77
4
MNST
49
-3
AEP
58
2
WHR
55
-2
MAS
67
-3
MAT
51
-3
HOG
50
6
MSI
72
2
COST
56
3
IVZ
50
-3
OMC
64
-2
EFX
63
-6
WMB
60
4
HP
41
-4
FLR
52
4
FRT
36
-2
ACN
56
13
PRGO
44
-2
SWK
81
-3
C
60
-2
SWN
77
4
MNST
49
-3
AEP
58
2
WHR
55
-2
MAS
67
-3
MAT
51
-3
HOG
50
6
MSI
72
2
COST
56
3
IVZ
50
-3
OMC
64
-2
EFX
63
-6
WMB
60
4
Financhill
Back

Energy And Water Development Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
25

EAWD
Energy And Water Development

Last Price:
0.0200
Seasonality Move:
-19.63%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
25
Energy And Water Development (EAWD) is a Sell

Is Energy And Water Development a Buy, Sell or Hold?

  • The current Energy And Water Development [EAWD] share price is $0.0170. The Score for EAWD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • EAWD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

EAWD Stock Price Chart

What is Energy And Water Development's stock price today?

  • The Energy And Water Development share price today is $0.0170
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EAWD is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

EAWD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 32.62 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.0157 - 0.0357) Sell
Bollinger Bands (100): (0.0275 - 0.0675) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

EAWD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.02 Sell
20-day SMA: 0.02 Sell
50-day SMA: 0.04 Sell
200-day SMA: 0.06 Sell
8-day EMA: 0.02 Sell
20-day EMA: 0.02 Sell
50-day EMA: 0.03 Sell
200-day EMA: 0.05 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Energy And Water Development Earnings Growth & EAWD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Energy And Water Development Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):